Clinical trial
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
NCT02534896 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 30, 2015
- Completion date
- June 30, 2018
- Enrollment
- 150 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
active rheumatoid arthritis